Unknown

Dataset Information

Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.


ABSTRACT:

Objectives

To evaluate the real-world association between varenicline and neuropsychiatric adverse events (NPAEs) in general and chronic obstructive pulmonary disease (COPD) population with and without psychiatric disorders compared with nicotine replacement therapy (NRT) to strengthen the knowledge of varenicline safety.

Design

A retrospective cohort study.

Setting

Prescription database IADB.nl, the Netherlands.

Participants

New users of varenicline or NRT among general (≥18 years) and COPD (≥40 years) population. Psychiatric subcohort was defined as people prescribed psychotropic medications (≥2) within 6 months before the index date.

Outcome measures

The incidence of NPAEs including depression, anxiety and insomnia, defined by new or naive prescriptio

SUBMITTER: Wang Y 

PROVIDER: S-EPMC8154988 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature